Jaehoon Lee | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Jaehoon Lee
Affiliation Clinical Medicine; vascular and endovascular surgery
Country South Korea
Google Scholar View Profile
Documents 25
Citations 155
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0906-5236

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Abstract

Jaehoon Lee is a South Korean clinical medicine researcher whose documented work focuses on vascular and endovascular surgery. His publications address endovascular aneurysm repair, peripheral arterial disease, femorofemoral bypass, arteriovenous access thrombosis, and emerging procedural approaches. The research emphasizes anatomical assessment, graft performance, procedural feasibility, postoperative complications, and clinical outcomes. His studies include retrospective analyses, case-based investigations, and multicenter prospective research, reflecting an applied approach to vascular care. The publication record demonstrates sustained interest in improving revascularization strategies, evaluating vascular devices, and identifying factors associated with treatment outcomes. These contributions support consideration for an Innovative Research Award in Clinical Medicine.

Keywords

Vascular surgery; endovascular surgery; peripheral arterial disease; endovascular aneurysm repair; abdominal aortic aneurysm; femorofemoral bypass; saphenous vein graft; polytetrafluoroethylene; vascular access; arteriovenous fistula; thrombosis; rotational atherectomy; infrainguinal arterial disease; revascularization; graft patency; iliac branch device; arterial anatomy; vascular devices; clinical outcomes; postoperative complications; predictive modeling; machine learning; atherosclerosis; clinical medicine.

Introduction

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Research Profile

Jaehoon Lee’s research profile centers on vascular and endovascular surgery, with publications involving abdominal aortic aneurysm repair, femorofemoral bypass, arteriovenous access, and infrainguinal arterial disease. His documented work reflects clinically oriented investigation, retrospective and multicenter study designs, procedural assessment, and evaluation of anatomical or treatment factors affecting outcomes today broadly. [2]

Research Contributions

Jaehoon Lee has contributed to clinical vascular research through studies evaluating endovascular aneurysm repair, graft selection, vascular access thrombosis, and contemporary peripheral interventions. His publications examine technical feasibility, anatomical change, graft patency, postoperative complications, and longer-term clinical outcomes, providing evidence relevant to decision-making in vascular surgery practice and patient care. [3]

Publications

Jaehoon Lee’s documented publication record includes research on changes following endovascular aneurysm repair, custom-made iliac branch devices, femorofemoral bypass graft selection, postoperative thrombosis of arteriovenous access, and predictive modeling of arteriovenous fistula occlusion. Recent multicenter research also examines rotational atherectomy with antirestenotic therapy for infrainguinal arterial disease. [1] [2]

Research Impact

Jaehoon Lee’s research has clinical relevance because vascular diseases require durable revascularization, careful anatomical assessment, and management of procedure-related complications. His studies address these needs through outcome-oriented analyses of bypass grafts, endovascular repair, dialysis access, and peripheral arterial interventions, supporting evidence-based refinement of vascular surgical and endovascular practice clinically directly. [3] [4]

Award Suitability

Jaehoon Lee demonstrates a research portfolio aligned with Innovative Research Award consideration in Clinical Medicine, particularly vascular and endovascular surgery. His documented studies investigate procedural strategies, device applications, graft alternatives, predictive modeling, and multicenter peripheral arterial treatment. The portfolio shows sustained clinical investigation and practical relevance to contemporary vascular care.[5]

Conclusion

Jaehoon Lee’s documented research demonstrates a consistent clinical focus on vascular and endovascular medicine, spanning aneurysm repair, peripheral arterial disease, bypass surgery, vascular access, and procedural innovation. The available publication record supports recognition of a clinically relevant research program that connects technical investigation with patient-centered outcomes and evolving vascular practice.[4]

References

  1. Lee JH, Park KH, Kwak SG. Changes in Neck Angle, Neck Length, Maximum Diameter, Maximum Area and Thrombus after Endovascular Aneurysm Repair. Vascular Specialist International. https://doi.org/10.5758/vsi.190054
  2. Park YE, Lee JH, Yun WS, Park KH. Surgeon custom-made iliac branch device to salvage hypogastric artery during endovascular aneurysm repair. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2014.29.12.1678
  3. Kwon G, Park KH, Kwak SG, Lee JH. The Results of Femorofemoral Bypass Using a Saphenous Vein Graft as an Alternative to PTFE Grafts. Vascular Specialist International. https://doi.org/10.5758/vsi.220060
  4. Kim J, Park K, Cho Y, Lee J. The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study. International Journal of Environmental Research and Public Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9690458/
  5. Lee JH, Kwak SG. Development of a Machine Learning-Based Predictive Model for Arteriovenous Fistula Occlusion After Surgery: A Retrospective Cohort Study from 2015 to 2025. Medicina. https://doi.org/10.3390/medicina61122150

Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Massimo Del Fabbro | Translational Research | Breakthrough Research Award

Published on by Health Scientists

Breakthrough Research Award

Massimo Del Fabbro
Università degli Studi di Milano, Italy
Massimo Del Fabbro
Researcher Massimo Del Fabbro
Affiliation Università degli Studi di Milano
Country Italy
Scopus ID 7004132028
Documents 584
Citations 15791
h-index 66
Subject Area Public Health
Event Health Scientists Awards
ORCID 0000-0001-7144-0984

The advancement of public health and healthcare sciences is strongly connected to the contributions of researchers whose scholarly activities support clinical innovation, evidence-based practice, and interdisciplinary scientific development. Massimo Del Fabbro, affiliated with Università degli Studi di Milano in Italy, has established a substantial academic presence through publications, citations, and collaborative healthcare investigations.[1] This article presents a structured overview of the academic profile, research contributions, and scholarly impact associated with the Breakthrough Research Award under the Health Scientists Awards initiative.[2]

Abstract

This article summarizes the scholarly achievements and academic influence of Massimo Del Fabbro in the field of public health and healthcare sciences. The overview examines publication productivity, citation indicators, institutional affiliations, and interdisciplinary scientific contributions associated with healthcare research and clinical advancement. The article additionally evaluates the relevance of these academic accomplishments within the framework of the Breakthrough Research Award presented by the Health Scientists Awards platform.[1][2]

Keywords

  • Public Health
  • Healthcare Sciences
  • Clinical Research
  • Epidemiology
  • Healthcare Innovation
  • Academic Recognition
  • Università degli Studi di Milano

Introduction

Research in public health and healthcare sciences contributes significantly to the development of clinical methodologies, healthcare management systems, and evidence-based medical practices. Recognition programs within the scientific community often emphasize the importance of sustained publication activity, citation influence, and interdisciplinary collaboration in advancing healthcare knowledge.[2] Massimo Del Fabbro has developed an extensive scholarly profile through contributions to healthcare and public health literature indexed within major academic databases. The researcher’s publication portfolio and citation performance indicate sustained scientific engagement and continued influence within healthcare-related disciplines.[1]

Research Profile

Massimo Del Fabbro is affiliated with Università degli Studi di Milano in Italy and has contributed extensively to scientific investigations related to healthcare sciences and public health. The Scopus author profile associated with Author ID 7004132028 reports 584 indexed documents, reflecting substantial research productivity and long-term academic participation.[1] The academic profile further demonstrates scholarly visibility through 15,791 citations and an h-index of 66. These indicators suggest broad dissemination of research findings and continuing recognition within the international scientific community.[1]

  • Institutional Affiliation: Università degli Studi di Milano
  • Primary Subject Area: Public Health
  • Indexed Publications: 584
  • Citation Count: 15,791
  • h-index: 66

Research Contributions

The scientific contributions associated with Massimo Del Fabbro involve clinical investigations, healthcare evaluation methodologies, epidemiological analysis, and evidence-based healthcare practices. These contributions support the advancement of medical research and provide relevant insights for healthcare professionals and policy-oriented scientific studies.[3] The researcher’s interdisciplinary collaborations and publication activities demonstrate active participation in scientific communication networks and international healthcare research initiatives.[4]

  • Clinical and healthcare research investigations
  • Public health and epidemiological analysis
  • Scientific collaboration in healthcare sciences
  • Evidence-based healthcare methodologies
  • Academic dissemination through indexed journals

Publications

The publication portfolio associated with Massimo Del Fabbro includes numerous articles indexed in internationally recognized academic databases and healthcare journals. The breadth of publications demonstrates consistent scientific activity and participation in interdisciplinary healthcare research initiatives.[1]

  1. Peer-reviewed scientific articles related to healthcare and public health sciences.
  2. Research publications indexed in Scopus and associated healthcare databases.
  3. Collaborative studies addressing healthcare innovation and clinical methodologies.
  4. Evidence-based publications supporting healthcare improvement and scientific advancement.

Research Impact

The citation metrics associated with Massimo Del Fabbro indicate substantial academic visibility and scientific influence within healthcare sciences and public health research. Citation-based indicators are commonly used to evaluate the dissemination and scholarly relevance of scientific publications across academic communities.[1] The combination of publication productivity, interdisciplinary research participation, and citation performance contributes to the researcher’s academic standing and supports continuing engagement in international scientific discourse related to healthcare innovation and evidence-based medicine.[3]

Award Suitability

The Breakthrough Research Award recognizes researchers who demonstrate sustained scientific productivity, interdisciplinary impact, and measurable scholarly influence. Based on publication activity, citation metrics, and healthcare-related research engagement, Massimo Del Fabbro demonstrates several characteristics commonly associated with scientific recognition initiatives.[2] The combination of extensive academic publications, international research visibility, and measurable citation influence supports the relevance of this recognition within the Health Scientists Awards framework and broader scientific community.[1]

Conclusion

Massimo Del Fabbro has contributed significantly to healthcare sciences and public health research through scientific publications, interdisciplinary collaboration, and evidence-based healthcare investigations. The researcher’s publication record, citation performance, and international academic visibility demonstrate continued engagement with scientific advancement and healthcare innovation. This article provides a structured academic overview associated with the Breakthrough Research Award and highlights scholarly contributions within healthcare and public health sciences.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Massimo Del Fabbro, Author ID 7004132028. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7004132028
  2. Health Scientists Awards. (n.d.). Breakthrough Research Award and Health Scientists Awards overview.
    Health Scientists Awards
  3. ORCID. (n.d.). ORCID profile of Massimo Del Fabbro.
    https://orcid.org/0000-0001-7144-0984
  4. Google Scholar. (n.d.). Google Scholar citation profile for Massimo Del Fabbro.
    https://scholar.google.com/citations?user=iaV7iGwAAAAJ&hl=en&oi=ao

  5. Capelli, M., Zuffetti, F., Del Fabbro, M., & Testori, T. Immediate rehabilitation of the completely edentulous jaw with fixed prostheses supported by either upright or tilted implants: a multicenter clinical study.

    https://pubmed.ncbi.nlm.nih.gov/17929526/

Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assist. Prof. Dr. Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assistant Professor | University General Hospital of Patras | Greece

Dr. Eirini Kostopoulou is an Assistant Professor of Paediatric Endocrinology at the University of Patras School of Medicine, with advanced clinical and research training in Greece and leading academic hospitals in the United Kingdom. Her expertise spans paediatric obesity, monogenic and syndromic obesity, type one diabetes mellitus, growth and thyroid disorders, congenital hyperinsulinism, and lipid abnormalities. Her research focuses on molecular and genetic mechanisms underlying metabolic and endocrine diseases, including growth hormone signaling, oxidative stress, apoptotic pathways, and rare genetic causes of obesity, with direct translational impact on diagnosis and targeted therapies. She has authored a substantial body of peer-reviewed publications with strong citation impact and has contributed extensively through invited lectures, international collaborations, and multicenter clinical studies. Her work has advanced precision medicine approaches in paediatric endocrinology, improved early diagnosis of rare disorders, and strengthened clinical management strategies with meaningful societal and public health relevance. She has 499 citations from 77 documents with an h-index of 12.

Citation Metrics (Scopus)

800
600
400
200
0

Citations
499

Documents
77

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Gao Yanjing | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Michele Ammendola | Translational Research | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Michele Ammendola | Translational Research | Research Excellence Award

Professor | Magna Graecia University | Italy

Professor Michele Ammendola is a distinguished surgeon and researcher specializing in digestive and general surgery, with a particular focus on translational research in oncology and gastrointestinal disorders. He serves at the Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy, and leads the Digestive Surgery Unit. His work integrates clinical practice with advanced research methodologies, contributing to the understanding of tumor neoangiogenesis, immune system interactions, and surgical innovations. Professor Ammendola has authored numerous scientific publications in internationally indexed journals and serves on editorial boards, reflecting his scholarly influence. He maintains active collaborations with leading institutions across Europe and beyond, advancing surgical techniques and patient-centered care. His research and clinical contributions have informed both practice and policy, fostering improved outcomes in complex surgical interventions and enhancing the broader societal understanding of gastrointestinal health and cancer management. He has 2559 citations from 130 documents with an h-index of 32.

Citation Metrics (Scopus)

3,000
2,000
1,000
0

Citations
2,559

Documents
130

h-index
32

🟦 Citations         🟥 Documents      🟩 h-index


View Scopus Profile

Featured Publications

Fatemeh Molaabasi | Health Technology | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Fatemeh Molaabasi | Health Technology | Best Researcher Award 

Assistant Professor | Breast Cancer Research Center, Motamed Cancer Institute, ACECR | Iran

Dr. Fatemeh Molaabasi is an accomplished scholar in analytical chemistry, biomaterials, and medical nanotechnology, serving as an Assistant Professor at the Motamed Cancer Institute, ACECR, where she contributes to the Biomaterials and Tissue Engineering and Medical Nanotechnology Research Groups. Her research advances bio-inspired nanomaterials for drug delivery, biosensing, regenerative medicine, cancer diagnostics, and theranostics, with a strong emphasis on clinically translatable platforms. She has produced a substantial body of peer-reviewed work in international journals and scholarly books and holds a record of impactful scientific contributions evidenced by a high citation profile and sustained editorial and reviewing responsibilities in leading journals. Dr. Molaabasi has pioneered innovative tools including tumor apoptosis assay platforms, viral detection systems, electrochemical biosensing strips, three-dimensional tumor models, and targeted diagnostic devices for circulating tumor cells, demonstrating excellence in merging chemistry, biology, engineering, and clinical needs. Her portfolio also includes the development of medical diagnostic kits, rapid assays, and dialysis-based devices designed to support metastatic cancer patients, reflecting a strong translational orientation toward patient-centered technology development. She has secured national funding, engaged in interdisciplinary and global research collaborations with leading academic and biomedical centers, and contributed to national innovation initiatives and industry-linked diagnostic technology development. Beyond research and innovation, she has actively served in editorial boards and scientific committees, reviewed national scientific grants, and mentored emerging researchers. Dr. Molaabasi’s work embodies a commitment to strengthening early cancer detection, precision medicine, and bio-nanotechnology infrastructure, while advancing sustainable and biocompatible nanoplatforms. Her efforts contribute to global research in cancer diagnostics and biosensors and to the development of affordable, high-performance biomedical technologies, reinforcing her role as a leader in next-generation healthcare innovation and applied nanoscience. She has 1274 citations from 55 documents with an h-index of 22.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Fathi Ganje Lou, E., Rezayan, A. H., Malekmohamadi, M., Abbasi, V., et al. (2025). Very simple and ultra-sensitive fluorescence resonance energy transfer aptasensor for turn-on C-reactive protein detection in biological matrices.

2. Feizi, F., Molaabasi, F., Ezati, M., Shamsipur, M., Mousavi, F., Roshanfekr, A., et al. (2025). Ratiometric fluorescence chiral sensors for pH monitoring and its applications in indicator paper and bioimaging. Analytical Chemistry.

3. Molaabasi, F., Mohseni, N., Hajipour-Verdom, B., Agheli, A., et al. (2025). Ultra-efficient label-free cell death detection based on multifunctional colorimetric fluorescent in-situ silver nanocluster/graphene nanohybridzyme and its application in environmental biological samples and cellular imaging. Biosensors and Bioelectronics.

4. Shahrashoob, M., Dehshiri, M., Yousefi, V., Moassesfar, M., Saberi, H., et al. (2025). Optical and electrochemical biosensors for detection of pathogens using metal nanoclusters: A systematic review. Biosensors.

5. Besharati, M., Radi, H. C., & Molaabasi, F. (2025). A highly sensitive and simple platform for enzyme-free detection of ethanol based on a nano-porous glassy carbon electrode with electrodeposited Ni nanoparticles. Russian Journal of Electrochemistry.

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Published on by Health Scientists

Dr. Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Research group leader | FIDIS/IDIS | Spain

Dr. Miguel García González is a distinguished biomedical researcher and Group Leader at the Instituto de Investigación Sanitaria de Santiago (IDIS/CHUS) in Spain, specializing in Molecular Genetics and Developmental Biology of Kidney Diseases. He earned his Ph.D. in Molecular Biology from the University of Santiago de Compostela, where he developed a strong foundation in genetics, molecular mechanisms, and translational nephrology. His research focuses on understanding the genetic and molecular bases of polycystic kidney disease (PKD) and related hereditary disorders, integrating genomic, cellular, and developmental biology approaches to identify novel therapeutic targets. Dr. García González has authored more than 40 peer-reviewed publications in high-impact journals such as Nature Medicine, PNAS, Kidney International, and Human Molecular Genetics, contributing significantly to the field’s understanding of renal pathophysiology. His work has received numerous national and international research grants and awards, recognizing his excellence in scientific innovation and mentorship. He actively participates in editorial and peer-review roles for several leading journals in nephrology and molecular biology, further influencing the direction of biomedical research. In addition to his research contributions, Dr. García González is deeply committed to training young scientists, supervising doctoral and postdoctoral researchers, and fostering interdisciplinary collaboration across clinical and molecular domains. His pioneering work continues to advance precision medicine approaches in nephrology, bridging basic science discoveries with clinical applications aimed at improving outcomes for patients with genetic kidney diseases. He has 1913 citations from 50 documents with an h-index of 20.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. (2025). Cell Communication and Signaling.

2. Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamics. (2025). Biochemical Pharmacology.

3. Characterization of recurrent UMOD variants (p.C255Y and p.Q316P) in a Galician cohort: Genotype–phenotype correlation and clinical implications. (2025). Nefrología.

4. Characterization of the functional component in human milk and identification of the molecular mechanisms undergoing prematurity. (2025). Clinical Nutrition.

5. HNF1B transcription factor: Key regulator in renal physiology and pathogenesis. (2025).